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Abstract
Introduction. Deficiency of vitamin D in pregnancy leads to higher incidences of preeclampsia, gestational diabetes, 
preterm birth, bacterial vaginosis, and also affects the health of the infants. According to Polish recommendations published 
in 2009, vitamin D supplementation in pregnant women should be provided from the 2nd trimester of pregnancy in daily 
dose of 800–1000 IU. The aim of the presented study is: 1) to estimate how many pregnant women comply with those 
recommendations and 2) to determine the 25(OH)D levels in pregnant women.   
Patients and methods. The study included 88 pregnant women, aged 20–40 years, between 12–35 week of gestation. 
Vitamin D concentrations [25(OH)D] were measured by a direct electrochemiluminescence immunoassay (Elecsys, Roche).  
Results. 31 of 88 pregnant women (35.2%) did not use any supplementation. Mean level of 25(OH)D was 28.8±14.8 ng/mL 
(range from 4.0 – 77.5 ng/mL). Vitamin D deficiency, defined as 25(OH)D concentration below 20 ng/mL, was found in 31.8% 
of the women (28/88). Insufficiency of vitamin D [25(OH)D concentration between 20–30 ng/mL] was present in 26.1% of the 
women (23/88). Optimal level of 25(OH)D (over 30 ng/mL) was present in 37/88 (42.0% women). Hence, in 46.2% of women 
taking vitamin D supplementation, the levels of 25(OH)D were still below 30 ng/mL.   
Conclusions. Supplementation of vitamin D in the investigated group was inadequate. More than 35% of pregnant women 
did not take any supplements, while half of the subjects who had declared taking vitamin D, failed to achieve optimal serum 
25(OH)D concentration.
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INTRODUCTION
Vitamin D3 (cholecalciferol) is not a vitamin in a true sense 
of the word, because the main source of vitamin D is skin 
synthesis, while less than 10% is derived from dietary sources 
[1]. The best known role of vitamin D is related to its effect 
on calcium homeostasis, in particular by increasing calcium 
absorption through amplification of calbindin synthesis, 
by the increased urinary calcium reabsorption; vitamin D 
is also involved in the regulation of parathyroid hormone 
synthesis [1].
Recently, non-skeletal effects of vitamin D have become 
the subject of interest [1, 2]. Potential extra-skeletal benefits 
of vitamin D intake include lower cardiovascular morbidity 
and mortality, the reduced risk of diabetes mellitus, colon 
cancer, multiple sclerosis, allergy, asthma and mental illness 
[3]. In addition to the above mentioned benefits, the adverse 
effects of vitamin D deficiency include rickets in children, 
bone fragility in adults caused by osteomalacia, osteoporosis 
and osteopenia [1].
During pregnancy, vitamin D regulates placental 
development and function [4], which suggests that maternal 
vitamin D status may be associated with adverse pregnancy 
outcomes, such as miscarriage, preeclampsia [5] and 
preterm birth [6]. Further risks of vitamin D deficiency 
in pregnant women include gestational diabetes [7] and 
bacterial vaginosis [8]. Low vitamin D supply in pregnant 
women may affect their offspring, because there is a strong 
correlation between maternal and cord blood 25(OH)D, and 
newborns have inadequate vitamin D stores to draw on in 
early life [9]. Children of vitamin D-deficient women are at 
risk for developing respiratory infections and asthma [10], 
type-1 diabetes [11], and schizophrenia [12] in the elderly. 
Rickets, low bone mineral density, and reduced postnatal 
linear growth and weight gain may also occur, particularly 
if postnatal supplementation of vitamin D is insufficient [13].
In Polish children, seasonal differences in body size were 
demonstrated; children born in the period from October 
– April were taller and heavier than those born from May – 
September. The authors explain these results being caused by 
only minimal sun exposure in Poland during winter period, 
and – in consequence – the lowest vitamin D production, 
providing indirect evidence of vitamin D deficiency in Poland 
and its consequence for the newborns [14].
National consultants in the field of paediatrics, 
endocrinology, gynecology, and other experts, established 
the Polish recommendations for prophylactic vitamin D 
supplementation. According to those recommendations 
(2009), vitamin D supplementation in pregnant women 
should be provided from the 2nd trimester of pregnancy in 
a daily dose of 800–1000 IU in cases of inadequate intake 
from diet and/or skin synthesis [15].
The aim of presented study was: 1) to estimate how many 
pregnant women comply with these recommendations 2) to 
determine 25(OH)D levels in pregnant women.
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PATIeNTs AND MeTHOD
The study included 88 Caucasian pregnant women, aged 
20–40 years, between 12 – week of gestation. Samples were 
collected from March – October 2011. 25(OH)D concentration 
was measured by a direct electrochemiluminescence 
immunoassay (Elecsys, Roche). The design of study was 
approved by the Ethics Committee of the Medical University 
in Lodz. Characteristics of the investigated subjects is 
presented in Table 1. The data were analysed by means of 
simple descriptive statistics of location and dispersion and 
Mann-Whitney`s U-test. Definition of vitamin D deficiency 
and insufficiency was based on the Endocrine Society’s 
Practice Guidelines on Vitamin D [16].
ResULTs
Thirty-one (35.2%) of the pregnant women did not 
use any supplementation. Mean level of 25(OH)D was 
28.83±14.84 ng/mL (mean+/-SD), ranging from 4.0 ng/mL 
– 77.5 ng/mL. Vitamin D deficiency, defined as 25(OH)
D concentration below 20 ng/mL was found in 31.8% of 
the women (28/88), while severe deficiency of vitamin D 
[25(OH)D concentration<10 ng/mL] was found in 4.5% 
of investigated women (4/88). Insufficiency of vitamin 
D [25(OH)D concentrations between 20–30 ng/mL] was 
detected in 26.1% of the subjects (23/88). Optimal levels of 
25(OH)D (over 30 ng/mL) were found in 37/88 (42.0% of the 
women). 25(OH)D concentration was significantly higher 
in women taking vitamin D supplements, compared with 
women who did not take vitamin D supplements (33.17 
±13.72 ng/mL vs. 21.23 ±13.27 ng/mL; p<0.05).
In 46.2% of the women who used vitamin D supplements 
and in 83% who did not use vitamin D supplements, the 
levels of 25(OH)D were below 30 ng/mL. Relative proportions 
of pregnant women, classified according to their 25(OH)D 
status with regards to vitamin D users and non-users, are 
shown in Fig 1. While comparing the users and non-users 
of vitamin D supplementation, it was found that non-users 
were significantly older and had a slightly lower BMI (Tab. 2).
DIsCUssION
The results of the presented study indicate that in Poland 
vitamin D supplementation in pregnant women is not 
optimal. Namely, vitamin D deficiency occurred in 31.8% 
of investigated women, while only 63.6% of pregnant women 
used the supplementation in question. Moreover, despite the 
use of supplementation, in 44.6% of the women the levels 
of 25(OH)D did not reach 30 ng/mL, which constituted 
the goal of the supplementation according to the Polish 
recommendations [15]. To date, the adherence of Polish 
pregnant women to prophylactic recommendations has only 
rarely been investigated. There is only one study, in which 
authors analyzed the diet of 512 Polish pregnant women, and 
demonstrated a lower consumption of vitamins, including 
vitamin D (2.64 µg/daily vs. 15 µg recommended) [17]. In that 
study, 79.7% of the pregnant women used vitamin-mineral 
supplements. However, diet provides less than 10% of the 
vitamin D daily requirement, while the rest comes from 
skin synthesis [1, 16]. Vitamin D deficiency in pregnancy 
undoubtedly reflects the vitamin D deficiency in Poland [18]; 
however, vitamin D deficiency in pregnancy has also been 
previously demonstrated in other countries [7, 19].
Mean level of 25(OH)D in the patients in the presented 
study was 28.8 ng/mL. This was higher than that shown in 
Belgium (20.4–22.7 ng/mL, n=1311) [19], Denmark (23.0 ng/
mL n=153) [7] and in South Australia (19.6 ng/mL, n=99) 
[20], although the last mentioned country is characterized by 
adequate sunlight, whereas in comparison with the presented 
data, the most similar results were reported from Canada, 
i.e. 25.6 ng/mL (n=226) [21].
In the presented study, severe deficiency of vitamin D 
[i.e. 25(OH)D <10 ng/mL] was found in only 4.5% of the 
investigated women, in contrast to 12.1% in Belgium [19], 32% 
in South Australia [20] and 1% in Canada [21]. In the present 
investigation, vitamin D deficiency, defined as 25(OH)D 
concentration below 20 ng/mL, was documented in 31.8% 
of subjects when compared to 44.6% in Belgium [19], 31% 
in Denmark [7] and 24% in Canada [21]. Higher 25(OH)D 
mean level, as observed here in comparison to other studies, 
may reflect seasonal variation of vitamin D, as our samples 
were taken from March–October.
The results also reflect ethnic homogeneity, as all subjects 
in the presented study were Caucasian, and there were no 
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Table 1. Characteristics of investigated women (n=88)
Mean±SD Median
Age [years]  31.44±4.70  32
Body mass [kg]  69.54±15.03  65
Height [cm] 165.30±5.77 165
BMI [kg/m2]  25.89±5.19  24.20
Week of pregnancy  21.89±6.85  22
Table 2. Comparison of users (n=57) and non-users of vitamin D 
supplementation (n=31)
Vitamin D 
supplementation users 
Vitamin D supplementation 
non-users
p
No. of women(%)   57 (64,7%)   31 (35,2%) -
25(OH)D [ng/mL]  33.17±13.72  21.23±13.27 <0.05
Age [years]  30.68±4.82  33±4.13 <0.05
Gestation week  21.6±6.9  22.76±6.8 NS
BMI [kg/m2]   25.75± 5.28  24.96±5.1 <0.05
Weight [kg]  67.45±16.03  70.55±14.64 <0.05
Height [cm] 165.36± 165.18±6.14 NS
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Figure 1. Relative proportions of 25(OH)D in women using and not using 
vitamin D supplements in pregnancy, classified as vitamin D deficiency [25(OH)
D concentrations <20 ng/mL), vitamin D insufficiency [25(OH)D concentrations 
between 20-30 ng/mL], vitamin D sufficiency [25(OH)D concentrations over 
30 ng/mL]Annals of Agricultural and Environmental Medicine 2014, Vol 21, No 1
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Muslim women whose religious beliefs influence their dress 
code. The lack of these ethnic differences might be important, 
since subjects with darker skin tend to have lower 25(OH)
D concentrations [9,19]. The self-reported character of data 
collection by pregnant women in the study may affect the 
accuracy of the information of the actual taking of vitamin D, 
the same applies to compliance with the rules of prophylaxis.
Deficiency of vitamin D in pregnancy, despite taking 
supplementation, may be a consequence of insufficient dose of 
vitamin D contained in multivitamin prenatal supplements, 
many of which contain only 400 IU or 500 IU, while Polish 
recommendations indicate that a dose of 400 IU is insufficient 
for providing an appropriate vitamin D status in pregnant 
women and their offspring. This may also explain the 
presented finding that 50% of the subjects who declared 
taking vitamin D, unfortunately failed to achieve optimal 
serum 25(OH)D concentrations. Similar data showing the 
ineffectiveness of a dose of 400 IU was shown by Vandevijvere 
[19] and Li [21]. However, compliance and persistence with 
the treatment should also be taken into consideration.
In conclusion, supplementation of vitamin D in the 
investigated group of Polish pregnant women was ineffective, 
since more than 35% of the pregnant women did not take any 
supplements, while almost 50% of the subjects who declared 
taking vitamin D failed to achieve optimal serum 25(OH)D 
concentration. Furthermore, physicians should be aware of 
the fact that supplements for pregnant women do not contain 
a sufficient amount of vitamin D.
Therefore, given the potential risk of vitamin D deficiency 
for pregnant women and their offspring, it is strongly 
recommend that randomized controlled trials on vitamin 
D supplementation during gestation should be performed.
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